Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Linda M. N. Hoang"'
Autor:
Benjamin Sobkowiak, Kimia Kamelian, James E. A. Zlosnik, John Tyson, Anders Gonçalves da Silva, Linda M. N. Hoang, Natalie Prystajecky, Caroline Colijn
Publikováno v:
BMC Genomics, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background The COVID-19 pandemic remains a global public health concern. Advances in sequencing technologies has allowed for high numbers of SARS-CoV-2 whole genome sequence (WGS) data and rapid sharing of sequences through global repositori
Externí odkaz:
https://doaj.org/article/f3542ed000544c0681ac4022651415bd
Autor:
Chenkai Li, Darcy Sutherland, S. Austin Hammond, Chen Yang, Figali Taho, Lauren Bergman, Simon Houston, René L. Warren, Titus Wong, Linda M. N. Hoang, Caroline E. Cameron, Caren C. Helbing, Inanc Birol
Publikováno v:
BMC Genomics, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background Antibiotic resistance is a growing global health concern prompting researchers to seek alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) are attracting attention again as therapeutic agents with promising uti
Externí odkaz:
https://doaj.org/article/c1bce5da554a4b7f99970badd19ff8ea
Autor:
Amelia Richter, Darcy Sutherland, Hossein Ebrahimikondori, Alana Babcock, Nathan Louie, Chenkai Li, Lauren Coombe, Diana Lin, René L. Warren, Anat Yanai, Monica Kotkoff, Caren C. Helbing, Fraser Hof, Linda M. N. Hoang, Inanc Birol
Publikováno v:
Antibiotics, Vol 11, Iss 12, p 1710 (2022)
Antimicrobial peptides (AMPs) are a diverse class of short, often cationic biological molecules that present promising opportunities in the development of new therapeutics to combat antimicrobial resistance. Newly developed in silico methods offer th
Externí odkaz:
https://doaj.org/article/aa2df13f90d04d4bb4d069a5df8c6fb1
Autor:
Diana Lin, Darcy Sutherland, Sambina Islam Aninta, Nathan Louie, Ka Ming Nip, Chenkai Li, Anat Yanai, Lauren Coombe, René L. Warren, Caren C. Helbing, Linda M. N. Hoang, Inanc Birol
Publikováno v:
Antibiotics, Vol 11, Iss 7, p 952 (2022)
Antibiotic resistance is a global health crisis increasing in prevalence every day. To combat this crisis, alternative antimicrobial therapeutics are urgently needed. Antimicrobial peptides (AMPs), a family of short defense proteins, are produced nat
Externí odkaz:
https://doaj.org/article/7845b064595447468c8c17b5d1390b6e
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 2016 (2016)
We evaluated the performance of 16S and internal transcribed spacer (ITS) region amplification and sequencing of rDNA from clinical specimens, for the respective detection and identification of bacterial and fungal pathogens. Direct rDNA amplificatio
Externí odkaz:
https://doaj.org/article/8b43f40fad7c4215b175699c6519fcd8
Autor:
Agatha N. Jassem, Natalie Prystajecky, Fawziah Marra, Pamela Kibsey, Kennard Tan, Patricia Umlandt, Loretta Janz, Sylvie Champagne, Bruce Gamage, George R. Golding, Michael R. Mulvey, Bonnie Henry, Linda M. N. Hoang
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 2016 (2016)
Background. Clostridium difficile is a major cause of gastrointestinal illness. Epidemic NAP1 strains contain toxins A and B, a deletion in repressor tcdC, and a binary toxin. Objectives. To determine the molecular epidemiology of C. difficile in Bri
Externí odkaz:
https://doaj.org/article/3ad9a93de9554c67bf359b3d69e2144d
Autor:
Afraz A. Khan, Hind Sbihi, Michael A. Irvine, Agatha N. Jassem, Yayuk Joffres, Braeden Klaver, Naveed Janjua, Aamir Bharmal, Carmen H. Ng, Amanda Wilmer, John Galbraith, Marc G. Romney, Bonnie Henry, Linda M. N. Hoang, Mel Krajden, Catherine A. Hogan
BackgroundPolymerase chain reaction (PCR) cycle threshold (Ct) values can be used to estimate the viral burden of Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2) and predict population-level epidemic trends. We investigated the use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::229a28e7303af10b33ce254b284ec022
https://doi.org/10.1101/2023.03.06.23286837
https://doi.org/10.1101/2023.03.06.23286837
Autor:
Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Hind Sbihi, Chris D Fjell, Eleni Galanis, Monika Naus, David M Patrick, Shiraz El Adam, May A Ahmed, Shinhye Kim, Bonnie Henry, Linda M N Hoang, Manish Sadarangani, Agatha N Jassem, Mel Krajden
Publikováno v:
The Journal of Infectious Diseases. 226:485-496
Background In British Columbia, Canada, most adults 50–69 years old became eligible for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in April 2021, with chimpanzee adenoviral vectored vaccine (ChAdOx1) restricted to ≥55-ye
Publikováno v:
Canadian Journal of Anaesthesia
Autor:
Danuta M Skowronski, Yossi Febriani, Manale Ouakki, Solmaz Setayeshgar, Shiraz El Adam, Macy Zou, Denis Talbot, Natalie Prystajecky, John R Tyson, Rodica Gilca, Nicholas Brousseau, Geneviève Deceuninck, Eleni Galanis, Chris D Fjell, Hind Sbihi, Elise Fortin, Sapha Barkati, Chantal Sauvageau, Monika Naus, David M Patrick, Bonnie Henry, Linda M N Hoang, Philippe De Wals, Christophe Garenc, Alex Carignan, Mélanie Drolet, Agatha N Jassem, Manish Sadarangani, Marc Brisson, Mel Krajden, Gaston De Serres
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(11)
Background The Canadian coronavirus disease 2019 (COVID-19) immunization strategy deferred second doses and allowed mixed schedules. We compared 2-dose vaccine effectiveness (VE) by vaccine type (mRNA and/or ChAdOx1), interval between doses, and time